| RUBICOR MEDICAL, INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110052505 | Post-biopsy cavity treatment implants and methods - A post-biopsy cavity treatment implant includes a radiopaque element, a core portion and a shell portion. The core portion is coupled to the radiopaque element, and includes a first porous matrix defining a first controlled pore architecture. The shell portion is coupled to the core portion and includes a second porous matrix defining a second controlled pore architecture that is different from the first controlled pore architecture. | 03-03-2011 |
| 20090263442 | Post Biopsy Cavity Treatment Implants and Methods - A post-biopsy cavity treatment implant includes a radiopaque element, a core portion and a shell portion. The core portion is coupled to the radiopaque element, and includes a first porous matrix defining a first controlled pore architecture. The shell portion is coupled to the core portion and includes a second porous matrix defining a second controlled pore architecture that is different from the first controlled pore architecture. | 10-22-2009 |
| 20090149746 | POST-BIOPSY CAVITY TREATMENT IMPLANTS AND METHODS - A method of forming a soft tissue biopsy cavity marker may include steps of providing a radio-opaque element and a bio-compatible and bio-degradable polymer such as alginate and delivering the provided radio-opaque element and the provided polymer to a biopsy site, such as a breast biopsy site. A gelling initiator that includes divalent cations such as NaCl | 06-11-2009 |
